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A 33-year-old woman sought medical attention for a painful swelling of the left ankle. Plain radiographs revealed an osteolytic
lesion involving the left distal tibia. An excisional biopsy provided the diagnosis of leiomyosarcoma in the tibia. A staging work-up
was performed and an abdominal CT showed 4 liver hypodense lesions in both lobes with peripheral contrast enhancement. A
liver biopsy conﬁrmed the diagnosis of epithelioid hemangioendothelioma of the liver. No association between these two entities
has been described before. This case introduces the importance of the pathological conﬁrmation of apparent metastatic lesions in
low grade sarcomas and provides a review of the literature of both tumours.
Copyright © 2008 E. Gonzalez-Billalabeitia et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1. CASE REPORT
Primary leiomyosarcoma of the tibia and epithelioid heman-
gioendothelioma of the liver are rare soft tissue sarcomas
with few cases reported. No association between these two
clinical entities has been described before. This case intro-
ducestheimportanceofthepathologicalconﬁrmationofap-
parent metastatic lesions.
A 33-year-old woman sought medical attention for a
two-month progressive painful swelling of the left ankle.
Plain radiographs revealed a 5cm osteolytic lesion involving
the left distal tibia metadiaphysis with cortical destruction
and no periosteal reaction (Figure 1). An excisional biopsy
was performed and the surgical defect was primarily recon-
structed with an autogenous free iliac crest bone graft. Light
microscopy revealed a tumor constituted mainly of spindle
cells with an interlaced pattern, enlarged shaped atypical nu-
clei and eosinophilic cytoplasm. Necrotic areas and colla-
gen bundles were apparent. No osteoid tissue was observed.
Immunohistochemical examination showed positive stain-
ing for smooth muscle actin (HHF-35 and IA-4), desmin,
and vimentin; and negative staining for cytokeratins (AE1
and AE3), S-100 protein, and CD31. The pathological diag-
nosiswasconsistentwithleiomyosarcomainthetibia.Anab-
dominal CT showed 4 liver hypodense lesions in both lobes,
the longest 3cm in length with peripheral contrast enhance-
ment(Figure 2).Anexhaustiveextensionstudythatincluded
agynecologicalexamination,bonescan,andthoracicCTob-
served no other lesions. A liver MRI conﬁrmed the existence
of four lesions, with low signal intensity on T1-weightened
images and high signal intensity on T2-weightened images,
and gadolinium enhancement. A positron emission tomog-
raphy was performed and 2 enhancements were observed in
hepatic segment VII and VIII, with a standard uptake value
(SUV) of 2.8.
The woman sought medical attention at our hospital.
Due to the atypical clinical presentation and course, a liver
biopsy was performed. Macroscopically there was a white,
ﬁrm lesion. Histologically the tumor was composed of a ﬁ-
brous stroma, with myxohyaline areas, as well as epithelioid
and dendritic cells containing intracellular vacuoles. Im-
munohistochemistry revealed positive staining for endothe-
lial markers CD31 and CD34, cytokeratin (AE1 and AE3),
andvimentin.Smoothmuscleactin(HHFand1A4),desmin,2 Sarcoma
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Figure 1: (a) Conventional radiograph reveals an osteolytic lesion in metadiaphysis of the left distal tibia with cortical destruction. (b) T1-
WeightenedMagneticResonanceImageshowsawell-deﬁnedlowdensityintramedullarylocationwithcorticalbreakthrough.(c)Interlacing
bundles of spindle cells with enlarged shaped atypical nuclei and eosinophilic cytoplasm (H&E, x40). (d) Tumor cells are immunostained by
the antibody against Actin HHF-35.
and S-100 protein staining were negative. The pathological
diagnosis was consistent with epithelioid hemangioendothe-
lioma. Both pathological samples were compared by two dif-
ferentpathologistsconﬁrmingthecoexistenceoftwodistinct
pathological entities. Chemotherapy was no longer contin-
ued, and a watch and wait policy was assumed. The patient
is four years later under close follow-up with no evidence of
progression of the epithelioid hemangioendothelioma of the
liver and no signs of recurrence of the leiomyosarcoma in the
tibia.
Primary leiomyosarcoma of the bone is a very rare tumor
ﬁrst reported by Evans and Sanerkin [1]. Many cases have
been reported since then [2] most in facial bones with ex-
trafacial cases accounting for less than a hundred. The most
frequently involved sites are the femur and the tibia. Median
age of presentation is about 40 years. The typical clinical pre-
sentation is a progressive painful swelling with a palpable
mass. Time to diagnosis usually exceeds 6 months. Patholog-
ical characteristics of the leiomyosarcoma of bone are similar
to leiomyosarcoma in other locations. Immunohistochem-
istry showing smooth muscle antigens strongly suggest the
diagnosis. Leiomyosarcoma usually arises in the uterus, gas-
trointestinal tract, or soft tissue. All these locations should be
carefully excluded to assess primary origin. Despite primary
lesions tending to be higher, purely osteolytic and with a
distal predomination, diﬀerentiation from secondary lesions
may be diﬃcult. Primary leiomyosarcoma of the bone can
metastasize to the lung, followed by lumbar spine and liver.
The best treatment is to resect the whole tumor. Chemother-
apy and radiotherapy are of unknown eﬃcacy.
Epithelioid hemangioendothelioma is an infrequent soft
tissue tumor of vascular origin. It was ﬁrst described in
the lung by Dail and Liebow [3]. Initially, it was known
as intravascular bronchioloalveolar tumor (IVBAT). Ultra-
structural examination and the immunochemical expres-
sion of factor VIII-related antigen demonstrated the vascu-
lar nature of this tumor. Weiss and Enzinger [4]d e s c r i b e da
group of soft tissue tumors of endothelial origin with a clini-
cal course intermediate between hemangioma and angiosar-
coma, which they called epithelioid hemangioendothelioma
(EHE). Less than three hundred cases involving the liver are
available in the literature. The larger clinicopathologic study
involving 137 cases was published by Makhlouf et al. [5].
Median age of diagnosis is 46 years, with a slight predom-
inance in females. The clinical course ranges from asymp-
tomatic diagnosis to liver failure. The most frequent pre-
sentation is a nonspeciﬁc pain in the right upper quadrant.
Pathologic diagnosis is based on the demonstration of theE. Gonzalez-Billalabeitia et al. 3
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Figure 2: (a) Abdominal computed tomography showing an hy-
podense lesion in the liver. (b) Tumor composed of ﬁbrous stroma
with myxohyaline areas containing epithelioid cells with intracellu-
lar vacuoles (H&E, x20). (c) Tumor cells are immunostained with
antibody to CD34.
vascularnatureofthetumor.Histologicallyitiscomprisedof
a ﬁbrous stroma with myxohyaline areas with dendritic and
epithelioid cells often containing intracellular vacuoles. Im-
munohistochemistry shows expression of endothelial anti-
gens such as factor VIII-related antigen, CD34, or CD31.
High cellularity more than mitotic count predicts an unfa-
vorable prognosis. There is an apparent dissociation between
the biologic characteristics of this tumor and the clinical be-
havior. The clinical course is unpredictable with prolonged
survival described up to 27 years without treatment and
morethan43%ofpatientslivelongerthan5years.Treatment
options are limited by the rarity of the tumor. Complete sur-
gical excision should be performed if possible. Despite being
believed to be resistant to chemotherapy and radiotherapy,
responses to doxorubicin, thalidomide, and interferon have
been reported. Partial spontaneous regression has also been
described.Orthotopiclivertransplantationistheonlyoption
in patients with progressive liver failure. To date no associa-
tion between these tumors has been described.
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